DNA hypermethylation: When tumour suppressor genes go silent

Human Genetics

Volumn 111, Issue 2, 2002, Pages 115-127

  Garinis, George A ^a   Patrinos, George P ^a,b   Spanakis, Nick E ^a   Menounos, Panayiotis G ^a  

^a Nursing Military Academy   (Greece)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; BRCA1 PROTEIN; CASPASE 8; COLLAGENASE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOOXYGENASE 2; DNA; DNA METHYLTRANSFERASE; ENDOTHELIN 1; FRAGILE HISTIDINE TRIAD PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METALLOTHIONEIN; PROTEIN MLH1; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P53; PROTEIN P73; PROTEIN SERINE THREONINE KINASE; RETINOIC ACID RECEPTOR BETA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ADENOMATOUS POLYP; AGING; CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; CELL SPREADING; DNA METHYLATION; DNA REPLICATION; DNA TRANSCRIPTION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HYPOTHESIS; MAMMAL; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; PROMOTER REGIONS (GENETICS);

EID: 0036705608     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0783-6     Document Type: Review

References (112)

1. Ahuja N, Issa JP (2000) Aging, methylation and cancer. Histol Histopathol 15:835-842
2. Araujo FD, Knox JD, Ramchandani S, Pelletier R, Bigey P, Price G, Szyf M, Zannis-Hadjopoulos M (1999) Identification of initiation sites for DNA replication in the human DNMT1 (DNA-methyltransferase) locus. J Biol Chem 274:9335-9341
3. Ashizawa S, Nishizawa H, Yamada M, Higashi H, Kondo T, Ozawa H, Kakita A, Hatakeyama M (2001) Collective inhibition of pRB family proteins by phosphorylation in cells with p16INK4a loss or cyclin E overexpression. J Biol Chem 276:11362-11370
4. Barlow DP (1995) Gametic imprinting in mammals. Science 270:1610-1613
5. Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Ohta M, Huebner K (1996) Fhit, a putative tumour suppressor in humans, is a dinucleoside 5′-5‴-P1,P3-triphosphate hydrolase. Biochemistry 35:11529-11535
6. Becker PB, Ruppert S, Schutz G (1987) Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors. Cell 51:435-443
7. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596-599
8. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG (1998) Aberrant methylation of p16 (INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891-11896
9. Berns EMJJ, Klijn JGM, Smid M, Van Staveren IL, Gruis NA, Foekens JA (1995) Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancers. Br J Cancer 72:964-967
10. Berx G, Becker KF, Hofler H, Van Roy F (1998) Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226-237
11. Bird A (1992) The essentials of DNA methylation. Cell 70:5-8
12. Bird AP, Wolffe AP (1999) Methylation-induced repression-belts, braces and chromatin. Cell 99:451-454
13. Boardman LA, Schmidt S, Lindor NM, Burgart LJ, Cunningham JM, Price-Troska T, Snow K, Ahlquist DA, Thibodeau SN (2001) A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair. Genes Chromosom Cancer 30:181-186
14. Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E (2001) Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 159:831-835
15. Boyes J, Bird A (1992) Repression of genes by DNA methylation depends on CpG density and promoter strength: Evidence for involvement of a methyl-CpG binding protein. EMBO J 11:327-333
16. Brener AJ, Aldaz CM (1995) Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelium. Cancer Res 55:2892-2895
17. De Carvalho CV, Harris WH, Xu CF, Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics. Oncogene 18:1957-1965
18. Catteau A, Harris WH, Xu CF, Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics. Oncogene 18: 1957-1965
19. Compere SJ, Palmiter RD (1981) DNA methylation controls the inducibility of the mouse metallothionein-I gene lymphoid cells. Cell 25:233-240
20. Constancia M, Pickard B, Kelsey G, Reik W (1998) Imprinting mechanisms. Genome Res 8:881-900
21. Delgado S, Gomez M, Bird A, Antequera F (1998) Initiation of DNA replication at CpG islands in mammalian chromosomes. EMBO J 17:2426-2435
22. Dong SM, Kim HS, Rha SH, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7:1982-1986
23. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR (2001) Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 92:404-408
24. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG (2000a) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60:4366-4371
25. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG (2000b) Hypermethylation-associated inactivtion of p14 (ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60:129-133
26. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229
27. Fulda S, Kufer MU, Meyer E, Van Valen F, Dockhorn-Dworniczak B, Debatin KM (2001) Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20:5865-5877
28. Garcia JF, Villuendas R, Algara P, Saez AI, Sanchez-Verde L, Martinez-Montero JC, Martinez P, Piris MA (1999) Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease. Lab Invest 79:1453-1459
29. Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Fiels J, Kittas C (2001) Association of the allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). J Pathol 193:55-65
30. Garinis GA, Menounos PG, Spanakis NE, Papadopoulos G, Karavitis G, Parassi I, Christelli E, Patrinos GP, Manolis EN, Peros G (2002) Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol (in press)
31. Gayther SA, Wells D, SenGupta SB, Chapman P, Neale K, Tsioupra K, Delhanty JD (1994) Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet 3:53-56
32. Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E (1998) Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene 16:497-504
33. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH (2002) Methylation-specific oligonucleotide microarray: A new potential for high-throughput methylation analysis. Genome Res 12:158-164
34. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG (2000) Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275:2727-2732
35. Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, Satoh S, Akao T, Sato K, Ogawa O, Knowles MA, Kato T (2001) Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Oncogene 20:531-537
36. Han L, Lin IG, Hsieh CL (2001) Protein binding protects sites on stable episomes and in the chromosome from de novo methylation. Mol Cell Biol 21:3416-3424
37. Hayashizaki Y, Hirotsune S, Okazaki Y, Hatada I, Shibata H, Kawai J, Hirose K, Watanabe S, Fushiki S, Wada S (1993) Restriction landmark genomic scanning method and its various applications. Electrophoresis 14:251-258
38. Hellmann-Blumberg U, Hintz MF, Gatewood JM, Schmid CW (1993) Developmental differences in methylation of human Alu repeats. Mol Cell Biol 13:4523-4530
39. Herman JG, Baylin SB (2000) Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 249:35-54
40. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826
41. Holler M, Westin G, Jiricny J, Schaffner W (1988) Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2:1127-1135
42. 4A) asymmetrical hydrolase: Sequence similarity with histidine triad (HIT) family. Biochem J 312:925-932
43. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540
44. Iwama T (2001) Somatic mutation rate of the APC gene. Jpn J Clin Oncol 31:185-187
45. Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, Dausman J, Lee P, Wilson C, Lander E, Jaenisch R (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27:31-39
46. Johnson CA, Turner BM (1999) Histone deacetylases: Complex transducers of nuclear signals. Semin Cell Dev Biol 10:179-188
47. Jones PA, Takai D (2001) The role of DNA methylation on mammalian epigenetics. Science 293:1068-1070
48. Jost JP, Siegmann M, Sun L, Leung R (1995) Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J Biol Chem 270:9734-9739
49. Jubb AM, Bell SM, Quirke P (2001) Methylation and colorectal cancer. J Pathol 195:111-134
50. Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, Hosokawa M, Imai K (2002) Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int J Cancer 97:272-277
51. Kochanek S, Renz D, Doerfler W (1995) Transcriptional silencing of human Alu sequences and inhibition of protein binding in the box B regulatory elements by 5′-CG-3′ methylation. FEBS Lett 360:115-120
52. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP (2002) Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8:131-137
53. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205
54. Leonhardt H, Cardoso MC (2000) DNA methylation, nuclear structure, gene expression and cancer. J Cell Biochem 35 (Suppl):78-83
55. Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF (1995) Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem 270:26750-26753
56. Liang G, Chan MF, Tomigahara Y, Tsai YC, Gonzales FA, Li E, Laird PW, Jones PA (2002) Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol Cell Biol 22:480-491
57. Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG (2001) Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res 61:8611-8616
58. Liu WM, Schmid CW (1993) Proposed roles for DNA methylation in Alu transcriptional repression and mutational inactivation. Nucleic Acids Res 21:1351-1359
59. Lopatina N, Haskell JF, Andrews LG, Poole JC, Saldanha S, Tollefsbol T (2002) Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem 84:324-334
60. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M (2001) E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20:1525-1528
61. Magdinier F, Ribieras S, Lenoir GM, Frappart L, Dante R (1998) Down-regulation of BRCA1 in human sporadic breast cancer; Analysis of DNA methylation patterns of the putative promoter region. Oncogene 17:3169-3176
62. Magdinier F, Billard LM, Wittmann G, Frappart L, Benchaib M, Lenoir GM, Guerin JF, Dante R (2000) Regional methylation of the 5′ end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J 14:1585-1594
63. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499-507
64. Mohandas T, Sparkes RS, Shapiro LJ (1981) Reactivation of an inactive human X chromosome: Evidence for X inactivation by DNA methylation. Science 211:393-396
65. Myohanen SK, Baylin SB, Herman JG (1998) Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 58:591-593
66. Nakamura M, Yonekawa Y, Kleihues P, Ohgaki H (2001) Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest 81:77-82
67. Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M, Zhou JH, Benedict WF, Jones PA (2001) Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 93:1465-1472
68. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R, Yasui W (2001) Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 93:805-809
69. Ping Siu LL, Cheung Chan JK, Wong KF, Kwong YL (2002) Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol 160:59-66
70. Pogribny IP, James SJ (2002) Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Cancer Lett 176:169-174
71. Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678-680
72. Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER (1997) Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. Am J Hum Genet 60:765-771
73. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000
74. Quesnel B, Feneaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C, Peyrat JP (1995) Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 72:351-353
75. Reik W, Walter J (1998) Imprinting mechanisms in mammals. Curr Opin Genet Dev 8:154-164
76. Reynisdottir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9:1831-1845
77. Rice JC, Futscher BW (2000) Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res 28:3233-3239
78. Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, McKeown C, Sanders DS, Maher ER (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 8:607-610
79. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27:2291-2298
80. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25:338-342
81. Rush EB, Abouezzi Z, Borgen PI, Anelli A (1995) Analysis of MTS1/CDK4 in female breast carcinomas. Cancer Lett 89:223-226
82. Sakamoto Y, Kitazawa R, Maeda S, Kitazawa S (2001) Methylation of CpG loci in 5′-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines. J Cell Biochem 80:415-423
83. Segal E, Le Pecq JB (1986) Relationship between cellular diadenosine 5′,5‴-P1,P4-tetraphosphate level, cell density, cell growth stimulation and toxic stresses. Exp Cell Res 167:119-126
84. Shim YH, Kang GH, Ro JY (2000) Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 80:689-695
85. Shimada Y, Sato F, Watanabe G, Yamasaki S, Kato M, Maeda M, Imamura M (2000) Loss of fragile histidine triad gene expression is associated with progression of esophageal cancer. Cancer 89:5-11
86. Si HX, Tsao SW, Lam KY, Srivastava G, Liu Y, Wong YC, Shen ZY, Cheung AL (2001) E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 173:71-78
87. Sozzi G, Huebner K, Croce CM (1998) FHIT in human cancer. Adv Cancer Res 74:141-166
88. Su LK, Vogelstein B, Kinzler KW (1993) Association ofthe APC tumor suppressor protein with catenins. Science 262:1734-1737
89. Takai D, Yagi Y, Wakazono K, Ohishi N, Morita Y, Sugimura T, Ushijima T (2001) Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene 20:7505-7513
90. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455
91. Takeichi M (1995) Morphogenetic roles of classical cadherins. Curr Opin Cell Biol 7:619-627
92. Tien HF, Tang JH, Tsay W, Liu MC, Lee FY, Wang CH, Chen YC, Shen MC (2001) Methylation of the p15 (INK4B) gene in myelodysplastic syndrome: It can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol 112:148-154
93. Tompa R, McCallum CM, Delrow J, Henikoff JG, Van Steensel B, Henikoff S (2002) Genome-wide profiling of DNA methylation reveals transposon targets of chromomethylase3. Curr Biol 12:65-68
94. Trojan J, Brieger A, Raedle J, Esteller M, Zeuzem S (2000) 5′-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut 47:272-276
95. Turk PW, Laayoun A, Smith SS, Weitzman SA (1995) DNA adduct 8-hydroxyl-2′-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 16:1253-1255
96. Turker MS (1999) The establishment and maintenance of DNA methylation patterns in mouse somatic cells. Semin Cancer Biol 9:329-337
97. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF (2001a) Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin Cancer Res 7:1998-2004
98. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF (2001b) Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7:584-589
99. Watabe M, Nagafuchi A, Tsukita S, Takeichi M (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127:247-256
100. Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF (2001) Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48:367-371
101. Wijnhoven BP, Pignatelli M (1999) E-cadherin-catenin: More than a sticky complex. Lancet 354:356-357
102. Wimmer K, Zhu XX, Rouillard JM, Ambros PF, Lamb BJ, Kuick R, Eckart M, Weinhausl A, Fonatsch C, Hanash SM (2002) Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosom Cancer 33:285-294
103. Wolf SF, Migeon BR (1982) Studies of X chromosome DNA methylation in normal human cells. Nature 295:667-671
104. Wolffe AP, Jones PL, Wade PA (1999) DNA demethylation. Proc Natl Acad Sci USA 96:5894-5896
105. Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59:71-73
106. Yokochi T, Robertson KD (2002) Preferential methylation of unmethylated DNA by mammalian de novo DNA methyltransferase Dnmt3a. J Biol Chem 277:11735-11745
107. Young J, Simms LA, Biden KG, Wynter C, Whitehall V, Karamatic R, George J, Goldblatt J, Walpole I, Robin SA, Borten MM, Stitz R, Searle J, McKeone D, Fraser L, Purdie DR, Podger K, Price R, Buttenshaw R, Walsh MD, Barker M, Leggett BA, Jass JR (2001) Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: Parallel pathways of tumorigenesis. Am J Pathol 159:2107-2116
108. Young JI, Smith JR (2001) DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J Biol Chem 276:19610-19616
109. Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, Trias M, Wiencke JK (2000) Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 21:2057-2064
110. Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD (2001a) 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 61:3581-3585
111. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD (2001b) Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61:249-255
112. Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, Grotzer MA (2002) Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur J Cancer 38:83-91